Send to

Choose Destination
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Jan 15;101:228-32. doi: 10.1016/j.saa.2012.09.072. Epub 2012 Sep 29.

Distinction of leukemia patients' and healthy persons' serum using FTIR spectroscopy.

Author information

National Synchrotron Radiation Laboratory, University of Science and Technology of China, and The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, China.


In this paper, FTIR spectroscopy was applied to compare the serum from leukemia patients with the serum from healthy persons. IR spectra of leukemia patients' serum were similar with IR spectra of healthy persons' serum, and they were all made up of proteins, lipids and nucleic acids, etc. In order to identify leukemia patients' serum and healthy persons' serum, the H1075/H1542, H1045/H1467, H2959/H2931 ratios were measured. The H2959/H2931 ratio had the highest significant difference among these ratios and might be a useful factor for identifying leukemia patients' serum and healthy persons' serum. Furthermore, from curve fitting, the RNA/DNA (A1115/A1028) ratios were observed to be lower in leukemia patients' serum than those in healthy persons' serum. The results indicated FTIR spectroscopic study of serum might be a useful tool in the field of leukemia research and diagnosis.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center